Drug developer Asymchem Laboratories falls in Hong Kong debut

GUSHENGTANG HOLDINGS

10/12/2021 03:56

** Shares of chemical drug developer Asymchem Laboratories
Tianjin Co Ltd  6821.HK  trade as low as HK$369.20 in Hong Kong
debut, down 4.8% from the offer price 
    ** Stock last down 4.4% from the HK$388 apiece offering
price; seventh most actively traded by turnover  
    ** Tianjin-based co sold 18.42 mln shares in global
offering, raising HK$7.15 bln ($916.85 mln) to expand
manufacturing capacity and service offerings, and for R&D and
acquisitions  urn:newsml:reuters.com:*:nP8N2S9027
    ** Shares of Gushengtang Holdings  2273.HK  trade as high as
HK$34.25 in debut, up 18.1% from the offer price of HK$29
apiece, before giving up gains to trade 0.2% lower in late
morning 
    ** Guangdong, China-based traditional Chinese medicine group
sold 27.88 mln shares in global offering, raising HK$808.5 mln
($103.68 mln) to expand operation and strengthen supply chain
capability, and for R&D  urn:newsml:reuters.com:*:nFWN2ST18T
    ** Beijing-based CANbridge Pharmaceuticals Inc  1228.HK 
drops as much as 28.8% from the offer price in debut
 urn:newsml:reuters.com:*:nFWN2SK16S
    ** Rare disease treatment-focused medical group sold 56.25
mln shares at HK$12.18 each in its global offering, raising
HK$685 mln ($87.84 mln) for R&D and products commercialisation
    ** The Hang Seng Commerce & Industry Index  .HSNC  slips
0.7%, the healthcare index  .HSCIH  falls 2% and the Hang Seng
Index  .HSI  declines 0.5%
    
($1 = 7.7984 Hong Kong dollars)

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))